Blood disorders
Measurable residual disease in AML: questions about the report
AML MRD reports: understand the sample, assay, timing and limits before comparing results or discussing a change in treatment.
Medicina Turkey
Practical guides to planning treatment in Turkey, understanding hospital offers and preparing for consultations.
Guides: 34 · Blood disorders
Clear filtersBlood disorders
AML MRD reports: understand the sample, assay, timing and limits before comparing results or discussing a change in treatment.
Blood disorders
Acute leukaemia during pregnancy: urgent coordination of haematology and maternity care, patient communication and a second opinion without delaying care.
Blood disorders
Acute leukaemia hospital transfer: clinical acceptance, an up-to-date handover and responsibility throughout the journey before booking transport.
Blood disorders
Ph-positive ALL: connect the BCR::ABL1 report with the treatment rationale, response monitoring and continuity of care between centres.
Blood disorders
T-cell ALL second opinion: confirm lineage, define the pending decision and compare options using the actual treatment and response history.
Blood disorders
Relapsed ALL: record the confirmed site, exact treatment timeline and previous exposures to support a focused second opinion.
Blood disorders
CNS prophylaxis in ALL: why it can be prescribed without proven CNS disease and what to clarify about results, procedures and scheduling.
Blood disorders
ALL maintenance across countries: coordinate current prescriptions, laboratory review, medicine supply and urgent care without creating treatment gaps.
Blood disorders
Adolescent leukaemia transition: preserve treatment history, agree adult-team acceptance and support the young person through a clear clinical handover.
Blood disorders
CLL with TP53 or del17p: separate the reason to start treatment from genetic findings that influence which treatment is suitable.
Page 3 of 3